Norditropin FlexPro

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

GrowthPrader-Willi Syndrome

79 competitors in Growth

#DrugCompanyPhaseTrials

1

Growth Hormone

Pfizer

Phase 3

302

Neo-Synephrine

EExela Pharma Sciences, LLC.

Phase 3

13

Recombinant Human Growth Hormone

Changchun GeneScience Pharmaceutical Co., Ltd.

Phase 3

84

Piqray

Novartis

Phase 2

25

Acipimox

Boehringer Ingelheim

Phase 2

16

Zyloprim

Jazz Pharmaceuticals

Preclinical

17

Lenvima

Eisai

Preclinical

18

Zolymbus

AbbVie

Preclinical

19

Aricept

Eisai

Preclinical

110

TY-9591

TTYK Medicines, Inc

Phase 2

1Show 34 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Growth Hormone Deficiency4 trials

Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency

Not yet recruiting·SShenzhen Kexing Pharmaceutical Co., Ltd.·Phase 2/3·NCT07126288·268 enrolled

A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency

Completed·Novo Nordisk·Phase 1·NCT01706783·35 enrolled

Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

Completed·Novo Nordisk·Phase 2·NCT02616562·76 enrolled

Show 1 more trial

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)

Enrolling by invitation·Novo Nordisk··NCT03972345·750 enrolled

Growth1 trial

Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone

Completed·Novo Nordisk··NCT01327924·77 enrolled

Tics1 trial

Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx®

Completed·Novo Nordisk·Phase 1·NCT01034202·56 enrolled

Prader-Willi syndrome1 trial

Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome

Completed·KKarolinska University Hospital·N/A·NCT00372125·46 enrolled

Peptides1 trial

Diurnal Variation of Exogenous Peptides (GH Puls/Jurgita I)

Completed·—·Phase 2·NCT01090778·8 enrolled

1 more indication

Adult Subject1 trial

A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects

Completed·Novo Nordisk·Phase 1·NCT01943084·32 enrolled

Details

Drug Info

Related News